These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8227045)

  • 1. Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.
    Ciosek CP; Magnin DR; Harrity TW; Logan JV; Dickson JK; Gordon EM; Hamilton KA; Jolibois KG; Kunselman LK; Lawrence RM
    J Biol Chem; 1993 Nov; 268(33):24832-7. PubMed ID: 8227045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ER-27856, a novel squalene synthase inhibitor, on plasma cholesterol in rhesus monkeys: comparison with 3-hydroxy-3-methylglutaryl-coa reductase inhibitors.
    Hiyoshi H; Yanagimachi M; Ito M; Ohtsuka I; Yoshida I; Saeki T; Tanaka H
    J Lipid Res; 2000 Jul; 41(7):1136-44. PubMed ID: 10884296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.
    Amin D; Cornell SA; Gustafson SK; Needle SJ; Ullrich JW; Bilder GE; Perrone MH
    J Lipid Res; 1992 Nov; 33(11):1657-63. PubMed ID: 1464749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate.
    Magnin DR; Biller SA; Dickson JK; Logan JV; Lawrence RM; Chen Y; Sulsky RB; Ciosek CP; Harrity TW; Jolibois KG
    J Med Chem; 1995 Jul; 38(14):2596-605. PubMed ID: 7629799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
    Amin D; Cornell SA; Perrone MH; Bilder GE
    Arzneimittelforschung; 1996 Aug; 46(8):759-62. PubMed ID: 9125274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.
    Ugawa T; Kakuta H; Moritani H; Inagaki O; Shikama H
    Br J Pharmacol; 2003 May; 139(1):140-6. PubMed ID: 12746232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro.
    Wasko BM; Smits JP; Shull LW; Wiemer DF; Hohl RJ
    J Lipid Res; 2011 Nov; 52(11):1957-64. PubMed ID: 21903868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
    Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
    J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of squalene synthase in rat hepatic cells. Biochemical and immunochemical evidence.
    Stamellos KD; Shackelford JE; Shechter I; Jiang G; Conrad D; Keller GA; Krisans SK
    J Biol Chem; 1993 Jun; 268(17):12825-36. PubMed ID: 8509416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1204-9. PubMed ID: 15467236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of dolichol and cholesterol synthesis in microsomes and peroxisomes isolated from rat liver.
    Grünler J; Olsson JM; Dallner G
    FEBS Lett; 1995 Jan; 358(3):230-2. PubMed ID: 7843406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RPR 101821, a new potent cholesterol-lowering agent: inhibition of squalene synthase and 7-dehydrocholesterol reductase.
    Amin D; Rutledge RZ; Needle SJ; Hele DJ; Neuenswander K; Bush RC; Bilder GE; Perrone MH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):233-40. PubMed ID: 8717165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
    Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
    J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
    Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
    J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC; Zhao Z; Lopez D
    Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto Si; Yanagisawa I
    Bioorg Med Chem; 2003 Aug; 11(17):3735-45. PubMed ID: 12901918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate inhibitors of squalene synthase protect cells against cholesterol-dependent cytolysins.
    Pospiech M; Owens SE; Miller DJ; Austin-Muttitt K; Mullins JGL; Cronin JG; Allemann RK; Sheldon IM
    FASEB J; 2021 Jun; 35(6):e21640. PubMed ID: 33991130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.